Sanofi and Translate Bio commence Phase I influenza vaccine trial
Sanofi Pasteur and Translate Bio have commenced a Phase I clinical trial in the US to assess an investigational messenger ribonucleic acid (mRNA)-based vaccine candidate…
Filing Analytics
Clinical Trials Arena Sector Filing Sentiment Score (Last 12 months)
Clinical Trials Arena Sector Trending Regions in Company Filings (Last 12 months)
Top 10 Clinical Trials Arena Companies Filing Themes - 2020 Vs. 2019 and Top Companies in 2020
| Top 10 Themes | 2020 Rank | 2019 Rank | Top 5 Companies with Themes Mentions in 2020 |
|---|---|---|---|
| Regulation | 1 | 1 | PTC Therapeutics Inc | Sarepta Therapeutics Inc | Orchard Therapeutics Plc | Sage Therapeutics Inc | Tricida Inc |
| Patents | 2 | 2 | Solid Biosciences Inc | Editas Medicine Inc | Black Diamond Therapeutics Inc | Beam Therapeutics Inc | Agenus Inc |
| Geopolitics | 3 | 3 | Sarepta Therapeutics Inc | Jazz Pharmaceuticals Plc | Biogen Inc | Cipla Ltd | Orchard Therapeutics Plc |
| Generics | 4 | 4 | Teva Pharmaceutical Industries Ltd | Amneal Pharmaceuticals Inc | Amarin Corp Plc | Endo International Plc | Jazz Pharmaceuticals Plc |
| China Impact | 5 | 6 | BeiGene (Beijing) Co Ltd | FibroGen Inc | Hutchison China MediTech Ltd | Zai Lab Ltd | Cellular Biomedicine Group Inc |
| Emerging Economies | 6 | 5 | Cipla Ltd | Aurobindo Pharma Ltd | Sun Pharmaceutical Industries Ltd | Cadila Healthcare Ltd | Glenmark Pharmaceuticals Ltd |
| Sustainability | 7 | 8 | Shionogi & Co Ltd | Cipla Ltd | Daiichi Sankyo Co Ltd | Merck & Co Inc | Aurobindo Pharma Ltd |
| Cybersecurity | 8 | 7 | Revance Therapeutics Inc | Sarepta Therapeutics Inc | Vir Biotechnology Inc | Navidea Biopharmaceuticals Inc | Harpoon Therapeutics Inc |
| Drug Pricing | 9 | 9 | Cipla Ltd | Sage Therapeutics Inc | TG Therapeutics Inc | Horizon Therapeutics Plc | Regeneron Pharmaceuticals Inc |
| Addiction | 10 | 20 | Cardinal Health Inc | GB Sciences Inc | GW Pharmaceuticals Plc | Nexien Biopharma Inc | Cannabics Pharmaceuticals Inc |
Clinical Trials Arena Sector Filing Mentions (Last 12 months)
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Latest News
View More
Covaxin Phase III data shows jab to be 77.8% effective ahead of WHO meeting
Long-awaited data of Bharat Biotech’s Covid-19 vaccine Covaxin has demonstrated a 77.8% efficacy in Phase III trials. The Subject Expert Committee (SEC) met on Tuesday…
Histogen-Amerimmune’s emricasan yields positive results in Covid-19 trial
Histogen and its partner Amerimmune have reported top-line data from the Phase I clinical trial where emricasan was found to…
UK announces funding support to bolster clinical research
The UK Government has announced about £64m in funding to support patient-centred clinical research delivery across the country. This investment…
Oxford University adds ivermectin to PRINCIPLE trial for Covid-19
The University of Oxford in the UK has added ivermectin to the Platform Randomised Trial of Treatments in the Community…
Roche Alzheimer’s drug yields mixed results in WUSTL study
Washington University School of Medicine in St Louis (WUSTL) in the US has reported that Roche’s investigational drug, gantenerumab, lowered…
Company A-Z
View More
GlobalData
GlobalData exists to help businesses decode the future to profit from faster, more informed decisions.
